D-512
/ Wayne State University, Binghamton University, Michael J. Fox Foundation
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 26, 2026
Protection Against Cellular Toxicity from Rotenone Treatment by the Neuroprotective, Novel Multifunctional Antiparkinsonian Drug D-512.
(PubMed, J Pers Med)
- "The data presented here are consistent with previously reported neuroprotective properties of D-512. The multifunctional nature of D-512, which combines potent dopamine agonist activity with neuroprotective and other beneficial properties, may address therapeutic needs in PD beyond symptomatic relief and could have potential application across PD subgroups as part of a personalized therapeutic approach."
Journal • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 1
Of
1
Go to page
1